BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16563699)

  • 1. Neurocognitive performance and functional disability in the psychosis prodrome.
    Niendam TA; Bearden CE; Johnson JK; McKinley M; Loewy R; O'Brien M; Nuechterlein KH; Green MF; Cannon TD
    Schizophr Res; 2006 May; 84(1):100-11. PubMed ID: 16563699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.
    Fitzgerald D; Lucas S; Redoblado MA; Winter V; Brennan J; Anderson J; Harris A
    Aust N Z J Psychiatry; 2004 Jul; 38(7):501-10. PubMed ID: 15255822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients.
    Subotnik KL; Nuechterlein KH; Green MF; Horan WP; Nienow TM; Ventura J; Nguyen AT
    Schizophr Res; 2006 Jul; 85(1-3):84-95. PubMed ID: 16624529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associating functional recovery with neurocognitive profiles identified using partially ordered classification models.
    Jaeger J; Tatsuoka C; Berns S; Varadi F; Czobor P; Uzelac S
    Schizophr Res; 2006 Jul; 85(1-3):40-8. PubMed ID: 16690254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis.
    Pukrop R; Ruhrmann S; Schultze-Lutter F; Bechdolf A; Brockhaus-Dumke A; Klosterkötter J
    Schizophr Res; 2007 May; 92(1-3):116-25. PubMed ID: 17344028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects.
    Laes JR; Sponheim SR
    Schizophr Res; 2006 May; 84(1):121-31. PubMed ID: 16443348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive insight and verbal memory in first episode of psychosis.
    Lepage M; Buchy L; Bodnar M; Bertrand MC; Joober R; Malla A
    Eur Psychiatry; 2008 Aug; 23(5):368-74. PubMed ID: 18374546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW; Byun MS; Shin NY; Shin YS; Kim SN; Jang JH; Kwon JS
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders.
    Fagerlund B; Pagsberg AK; Hemmingsen RP
    Schizophr Res; 2006 Jul; 85(1-3):30-9. PubMed ID: 16626945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of neurocognitive function in individuals at-risk for psychosis.
    Keefe RS; Perkins DO; Gu H; Zipursky RB; Christensen BK; Lieberman JA
    Schizophr Res; 2006 Dec; 88(1-3):26-35. PubMed ID: 16930949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis.
    Kelleher I; Murtagh A; Clarke MC; Murphy J; Rawdon C; Cannon M
    Cogn Neuropsychiatry; 2013; 18(1-2):9-25. PubMed ID: 22991935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms.
    Hur JW; Shin NY; Jang JH; Shim G; Park HY; Hwang JY; Kim SN; Yoo JH; Hong KS; Kwon JS
    Aust N Z J Psychiatry; 2012 Feb; 46(2):161-9. PubMed ID: 22311532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No sex differences in neuropsychological performance in first episode psychosis patients.
    Ayesa-Arriola R; Rodriguez-Sanchez JM; Gomez-Ruiz E; Roiz-Santiáñez R; Reeves LL; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():149-54. PubMed ID: 24075821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?
    Villalta-Gil V; Vilaplana M; Ochoa S; Haro JM; Dolz M; Usall J; Cervilla J;
    Schizophr Res; 2006 Oct; 87(1-3):246-53. PubMed ID: 16859898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.